<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00954265</url>
  </required_header>
  <id_info>
    <org_study_id>rec-HCG 002</org_study_id>
    <nct_id>NCT00954265</nct_id>
  </id_info>
  <brief_title>Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)</brief_title>
  <official_title>Phase III Study on the Effects of Recombinant HCG Ovulation Triggering on Stimulation, Embryonic and Pregnancy Parameters in an IVF Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Serono International SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To access whether the ovulation triggering with rec-HCG instead urinary-HCG has any impact on
      the blastulation rate and pregnancy rate of patients undergoing IVF treatment
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2005</start_date>
  <completion_date type="Anticipated">September 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blastulation rate</measure>
    <time_frame>on day-5</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pregnancy rates, VEGF levels, OHSS rate</measure>
    <time_frame>14 days after oocyte pick up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Embryonic Development</condition>
  <condition>Pregnancy</condition>
  <condition>VEGF</condition>
  <arm_group>
    <arm_group_label>Urinary-HCG group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients received u-HCG for ovulation triggering during ovarian stimulation for IVF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recombinant HCG group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients received rec-HCG for ovulation triggering during ovarian stimulation for IVF</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10000 IU urinary HCG</intervention_name>
    <description>ovulation triggering</description>
    <arm_group_label>Urinary-HCG group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>250 mcg recombinant HCG</intervention_name>
    <description>ovulation triggering</description>
    <arm_group_label>Recombinant HCG group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  FSH&lt;12,

          -  normal sperm,less than 36y,

          -  single blastocyst transfer

        Exclusion Criteria:

          -  endometriosis stage 3&amp;4,

          -  pco
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Devroey, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Professor or OB-GYN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Reproductive Medicine, UZ Brussel</name>
      <address>
        <city>Brussels</city>
        <state>Jette</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.brusselsivf.be/default.aspx?lang=EN</url>
    <description>main web page of the centre for reproductive medicine in UZ Brussels</description>
  </link>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2009</study_first_submitted>
  <study_first_submitted_qc>August 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2009</study_first_posted>
  <last_update_submitted>December 23, 2009</last_update_submitted>
  <last_update_submitted_qc>December 23, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Papanikolaou Evangelos</name_title>
    <organization>Centre for Reproductive Medicine</organization>
  </responsible_party>
  <keyword>pregnancy occurence</keyword>
  <keyword>OHSS</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

